Interim Analysis (n=200) from ELEANOR: a Multinational, Prospective, Non-Interventional Study among Patients with HER2+and HR+ Early Breast Cancer Treated with Extended Adjuvant Neratinib in the Clinical Routine
CANCER RESEARCH(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined